首页> 外文期刊>Chemistry Select >Design,Synthesis,Molecular Docking,Molecular Dynamics and In Vivo Antimalarial Activity of New Dipeptide-Sulfonamides
【24h】

Design,Synthesis,Molecular Docking,Molecular Dynamics and In Vivo Antimalarial Activity of New Dipeptide-Sulfonamides

机译:设计,合成,分子对接,分子动力学和新二肽 - 磺酰胺的体内抗疟疾活性

获取原文
获取原文并翻译 | 示例
           

摘要

A new series of novel dipeptide sulfonamide analogues were designed,synthesized,and screened for their in silico studies and in vivo antimalarial activities.The synthesized compounds(50 mg/Kg)showed significant activity against P.berghei(NK65)with % inhibition values in(5.9 to 64.7%)range in when compared with reference drug,artemisinin(66.7%)in a four day suppressive assay.The in silico studies predicted favorable binding affinity of compounds with target protein residues with high dock score against P.falciparum falcipain 2(FP-2)and falcipain 3(FP-3)proteins in comparison with the reference ligands.The synthesized compounds showed druggable properties,and the predicted(absorption,distribution,metabolism,excretion and toxicities(ADMET)properties were within the acceptable limits.Molecular dynamics simulation study of the most active compound,8e was performed in order to further validate the stability of the protein-ligand complex and the protein-ligand interactions.
机译:设计,合成并筛选了一系列新的新型二肽磺酰胺类似物,并在体内抗性活性中进行了筛选。合成化合物(50 mg/kg)对P.Berghei(NK65)显示出显着的活性(NK65),其抑制值(NK65)具有明显的活性。 (5.9%至64.7%)与参考药物相比,四天抑制分析中的青蒿素(66.7%)相比。在硅研究中,该化合物的靶蛋白残基具有较高的dock评分对falciparum falcipain 2 与参考配体相比(FP-2)和Falcipain 3(FP-3)蛋白。合成的化合物显示出可药物的特性,并且预测(吸收,分布,代谢,排泄和毒性(ADMET)特性在可接受的限制范围内 。进行最活跃化合物的分子动力学仿真研究,以进一步验证蛋白质配体复合物和蛋白质配体相互作用的稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号